236 related articles for article (PubMed ID: 27556698)
21. TIPE2 functions as a metastasis suppressor via negatively regulating β-catenin through activating GSK3β in gastric cancer.
Wu J; Zhang H; Xu C; Xu H; Zhou X; Xie Y; Tao M
Int J Oncol; 2016 Jan; 48(1):199-206. PubMed ID: 26530498
[TBL] [Abstract][Full Text] [Related]
22. ILT3 promotes tumor cell motility and angiogenesis in non-small cell lung cancer.
Li J; Gao A; Zhang F; Wang S; Wang J; Wang J; Han S; Yang Z; Chen X; Fang Y; Jiang G; Sun Y
Cancer Lett; 2021 Mar; 501():263-276. PubMed ID: 33152402
[TBL] [Abstract][Full Text] [Related]
23. TNFAIP8L2/TIPE2 impairs autolysosome reformation via modulating the RAC1-MTORC1 axis.
Li W; Li Y; Guan Y; Du Y; Zhao M; Chen X; Zhu F; Guo C; Jia Y; Li Y; Wang X; Wang X; Shi Y; Wang Q; Li Y; Zhang L
Autophagy; 2021 Jun; 17(6):1410-1425. PubMed ID: 32460619
[TBL] [Abstract][Full Text] [Related]
24. [Microvessel density and expressions of survivin and vascular endothelial growth factor in non-small cell lung cancer and their correlations to clinicopathologic features].
Wang L; Li X; Li Y; Xue YW
Ai Zheng; 2005 Jul; 24(7):823-6. PubMed ID: 16004808
[TBL] [Abstract][Full Text] [Related]
25. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance.
Shen L; Yang M; Lin Q; Zhang Z; Zhu B; Miao C
Oncol Rep; 2016 Aug; 36(2):877-85. PubMed ID: 27373316
[TBL] [Abstract][Full Text] [Related]
26. TIPE2 Inhibits Lung Cancer Growth Attributing to Promotion of Apoptosis by Regulating Some Apoptotic Molecules Expression.
Liu QQ; Zhang FF; Wang F; Qiu JH; Luo CH; Zhu GY; Liu YF
PLoS One; 2015; 10(5):e0126176. PubMed ID: 25946186
[TBL] [Abstract][Full Text] [Related]
27. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
28. FBXO25 promotes cell proliferation, invasion, and migration of NSCLC.
Jiang GY; Zhang XP; Wang L; Lin XY; Yu JH; Wang EH; Zhang Y
Tumour Biol; 2016 Oct; 37(10):14311-14319. PubMed ID: 27596142
[TBL] [Abstract][Full Text] [Related]
29. TIPE2 Overexpression Suppresses the Proliferation, Migration, and Invasion in Prostate Cancer Cells by Inhibiting PI3K/Akt Signaling Pathway.
Lu Q; Liu Z; Li Z; Chen J; Liao Z; Wu WR; Li YW
Oncol Res; 2016; 24(5):305-313. PubMed ID: 27712587
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
[TBL] [Abstract][Full Text] [Related]
31. TIPE2 suppressed cisplatin resistance by inducing autophagy via mTOR signalling pathway.
Guo H; Ren H; Li J; Hao M; Hao J; Ren H; Guo L; Liu R
Exp Mol Pathol; 2020 Apr; 113():104367. PubMed ID: 31917287
[TBL] [Abstract][Full Text] [Related]
32. Cyclophilin B promotes cell proliferation, migration, invasion and angiogenesis via regulating the STAT3 pathway in non-small cell lung cancer.
Teng MR; Huang JA; Zhu ZT; Li H; Shen JF; Chen Q
Pathol Res Pract; 2019 Jun; 215(6):152417. PubMed ID: 31043353
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer.
Zhu X; Gao G; Chu K; Yang X; Ren S; Li Y; Wu H; Huang Y; Zhou C
Int J Biochem Cell Biol; 2015 Apr; 61():103-14. PubMed ID: 25687035
[TBL] [Abstract][Full Text] [Related]
34. TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location.
Wang G; Guo C; Zhao H; Pan Z; Zhu F; Zhang L; Wang Q
BMC Cancer; 2018 Mar; 18(1):260. PubMed ID: 29510688
[TBL] [Abstract][Full Text] [Related]
35. TIPE2 Induced the Proliferation, Survival, and Migration of Lung Cancer Cells Through Modulation of Akt/mTOR/NF-κB Signaling Cascade.
Bordoloi D; Banik K; Padmavathi G; Vikkurthi R; Harsha C; Roy NK; Singh AK; Monisha J; Wang H; Kumar AP; Kunnumakkara AB
Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31817720
[TBL] [Abstract][Full Text] [Related]
36. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
[TBL] [Abstract][Full Text] [Related]
37. Targeting neuropilin 1 as an antitumor strategy in lung cancer.
Hong TM; Chen YL; Wu YY; Yuan A; Chao YC; Chung YC; Wu MH; Yang SC; Pan SH; Shih JY; Chan WK; Yang PC
Clin Cancer Res; 2007 Aug; 13(16):4759-68. PubMed ID: 17699853
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of CASS4 promotes invasion in non-small cell lung cancer by activating the AKT signaling pathway and inhibiting E-cadherin expression.
Li A; Zhang W; Xia H; Miao Y; Zhou H; Zhang X; Dong Q; Li Q; Qiu X; Wang E
Tumour Biol; 2016 Nov; 37(11):15157-15164. PubMed ID: 27677288
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of RCN1 correlates with poor prognosis and progression in non-small cell lung cancer.
Chen X; Shao W; Huang H; Feng X; Yao S; Ke H
Hum Pathol; 2019 Jan; 83():140-148. PubMed ID: 30172915
[TBL] [Abstract][Full Text] [Related]
40. TNF receptor-associated factor 1 as a biomarker for assessment of non-small cell lung cancer metastasis and overall survival.
Wen X; Wang B; Feng T; Yuan W; Zhou J; Fang T
Clin Respir J; 2018 Jul; 12(7):2197-2203. PubMed ID: 29528567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]